714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT
Keyword(s):
Keyword(s):
2014 ◽
Vol 86
(10)
◽
pp. 1705-1713
◽
Keyword(s):
2004 ◽
Vol 351
(12)
◽
pp. 1206-1217
◽
Keyword(s):